The Evolving Understanding and Approach to Residual Cardiovascular Risk Management
Author:
Publisher
Frontiers Media SA
Subject
Cardiology and Cardiovascular Medicine
Reference111 articles.
1. Evolocumab and clinical outcomes in patients with cardiovascular disease;Sabatine;N Engl J Med,2017
2. Alirocumab and Cardiovascular outcomes after acute coronary syndrome;Schwartz;N Engl J Med,2018
3. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein;Ridker;N Engl J Med,2008
4. Intensive versus moderate lipid lowering with statins after acute coronary syndromes;Cannon;N Engl J Med,2004
5. Inhibition of lipoprotein-associated phospholipase A2 diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages;Carpenter;FEBS Lett.,2001
Cited by 101 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PGC1α enhances macrophage efferocytosis in ox-LDL-stimulated RAW264.7 cells by regulating the NLRP3/PPARα axis;Tissue and Cell;2024-10
2. Cardiac Magnetic Resonance Left Atrial Strain in the Prediction of Death, Ischemic Stroke, and Heart Failure;Journal of the American Heart Association;2024-09-03
3. Testing practices and clinical management of lipoprotein(a) levels: A 5-year retrospective analysis from the Johns Hopkins Hospital;American Journal of Preventive Cardiology;2024-09
4. Efficacy and safety of drugs in residual cardiovascular risk: A systematic review of the literature;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-09
5. The biogenesis and transport of triglyceride-rich lipoproteins;Trends in Endocrinology & Metabolism;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3